Back to search

University of Patras

Μεταβολές των Τ κυτταρικών υποπληθυσμών μετά από θεραπεία με check point inhibitors

Abstract

dc:description

The present study aims to explore the potential role of circulating lymphocytic subpopulations (T and Natural Killer) as biomarkers for response to checkpoint inhibitor (CPI) immunotherapy or for stratifying patients at high risk of developing immune-related adverse events. Twenty-one patients who were about to start treatment with a CPI (14 received nivolumab and 7 received pembrolizumab at standard doses) and eight healthy donors were enrolled. Peripheral blood mononuclear cells were obtained for flow cytometric analysis at five consecutive time points, pre- and post- treatment (up to six months). Total CD4+ lymphocytes were significantly decreased, whereas T helper 17 and regulatory T lymphocytes were significantly increased within non-Responders compared to healthy donors at treatment onset, indicating their potential significance for predicting non-response to anti-PD-1 immunotherapy. However, further validation is required.

Degree

thesis:*
Grantor dc:publisher
University of Patras
Year dc:date
2024

Author and committee

dc:creator, dc:contributor.*
Authors dc:creator
  • Salamaliki, Christina
  • Σαλαμαλίκη, Χριστίνα

Subjects

dc:subject × 16

Rights

Language dc:language
gre

Identifiers

dc:identifier.*
Identifier
10.12681/eadd/57879

Chain of custody

source
Harvested from
Greek National Archive of PhD Theses
Base URL
phdtheses.ekt.gr/eadd_oai/request
Last updated
2026-11-18
Source record
OAI-PMH GetRecord
citation

Salamaliki, Christina; Σαλαμαλίκη, Χριστίνα. Μεταβολές των Τ κυτταρικών υποπληθυσμών μετά από θεραπεία με check point inhibitors. University of Patras, 2024. http://hdl.handle.net/10442/hedi/57879